Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108822027 | 10882202 | 7 | F | 201501 | 20160707 | 20150303 | 20160718 | EXP | US-CELGENEUS-USA-2015024348 | CELGENE | 75.58 | YR | M | Y | 88.53000 | KG | 20160718 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108822027 | 10882202 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | B0021AA,B2005AA | 20785 | 200 | MG | CAPSULES | QD | |||||
108822027 | 10882202 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B0021AA,B2005AA | 20785 | 100 | MG | CAPSULES | QD | |||||
108822027 | 10882202 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B0021AA,B2005AA | 20785 | 100 | MG | CAPSULES | QD | |||||
108822027 | 10882202 | 4 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B0021AA,B2005AA | 20785 | 100 | MG | CAPSULES | ||||||
108822027 | 10882202 | 5 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | 0 | 5 | MG | UNKNOWN | ||||||||
108822027 | 10882202 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | 75 | MG | UNKNOWN | ||||||||
108822027 | 10882202 | 7 | C | LUMIGAN | BIMATOPROST | 1 | Ophthalmic | 0 | SOLUTION | ||||||||||
108822027 | 10882202 | 8 | C | Metformin HCl | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | TABLETS | ||||||||
108822027 | 10882202 | 9 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 65-25 MG | 0 | UNKNOWN | |||||||||
108822027 | 10882202 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLETS | ||||||||
108822027 | 10882202 | 11 | C | Triamterene/Hydrochlorothiazide | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 37.5-25 | 0 | CAPSULES | |||||||||
108822027 | 10882202 | 12 | C | Insulin | INSULIN NOS | 1 | Unknown | 0 | UNKNOWN | ||||||||||
108822027 | 10882202 | 13 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
108822027 | 10882202 | 1 | Plasma cell myeloma |
108822027 | 10882202 | 5 | Product used for unknown indication |
108822027 | 10882202 | 6 | Product used for unknown indication |
108822027 | 10882202 | 7 | Product used for unknown indication |
108822027 | 10882202 | 8 | Product used for unknown indication |
108822027 | 10882202 | 9 | Product used for unknown indication |
108822027 | 10882202 | 10 | Product used for unknown indication |
108822027 | 10882202 | 11 | Product used for unknown indication |
108822027 | 10882202 | 12 | Product used for unknown indication |
108822027 | 10882202 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
108822027 | 10882202 | OT |
108822027 | 10882202 | LT |
108822027 | 10882202 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
108822027 | 10882202 | Arterial rupture | |
108822027 | 10882202 | Cerebrovascular accident | |
108822027 | 10882202 | Diabetes mellitus inadequate control | |
108822027 | 10882202 | Diarrhoea | |
108822027 | 10882202 | Gout | |
108822027 | 10882202 | Thrombosis | |
108822027 | 10882202 | Vascular dementia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
108822027 | 10882202 | 1 | 200809 | 0 | ||
108822027 | 10882202 | 2 | 200902 | 0 | ||
108822027 | 10882202 | 3 | 20101105 | 0 | ||
108822027 | 10882202 | 4 | 20130125 | 0 |